Machine learning enables new insights into clinical significance of and genetic contributions to liver fat accumulation
Preprint
Abstract
Excess accumulation of liver fat – termed hepatic steatosis when fat accounts for > 5.5% of liver content – is a leading risk factor for end-stage liver disease and is strongly associated with important cardiometabolic disorders. Using a truth dataset of 4,511 UK Biobank participants with liver fat previously quantified via abdominal MRI imaging, we developed a machine learning algorithm to quantify liver fat with correlation coefficients of 0.97 and 0.99 in hold-out testing datasets and applied this algorithm to raw imaging data from an additional 32,192 participants. Among all 36,703 individuals with abdominal MRI imaging, median liver fat was 2.2%, with 6,250 (17%) meeting criteria for hepatic steatosis. Although individuals afflicted with hepatic steatosis were more likely to have been diagnosed with conditions such as obesity or diabetes, a prediction model based on clinical data alone without imaging could not reliably estimate liver fat content. To identify genetic drivers of variation in liver fat, we first conducted a common variant association study of 9.8 million variants, confirming three known associations for variants in the TM6SF2, APOE , and PNPLA3 genes and identifying five new variants associated with increased hepatic fat in or near the MARC1, ADH1B, TRIB1, GPAM and MAST3 genes. A polygenic score that integrated information from each of these eight variants was strongly associated with future clinical diagnosis of liver diseases. Next, we performed a rare variant association study in a subset of 11,021 participants with gene sequencing data available, identifying an association between inactivating variants in the APOB gene and substantially lower LDL cholesterol, but more than 10-fold increased risk of steatosis. Taken together, these results provide proof of principle for the use of machine learning algorithms on raw imaging data to enable epidemiologic studies and genetic discovery.Keywords
All Related Versions
- Published version: Cell Genomics, 1 (3).
This publication has 63 references indexed in Scilit:
- Characterization of European Ancestry Nonalcoholic Fatty Liver Disease-Associated Variants in Individuals of African And Hispanic DescentHepatology, 2013
- FTO genotype is associated with phenotypic variability of body mass indexNature, 2012
- ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestryMolecular Psychiatry, 2011
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic TraitsPLOS Genetics, 2011
- Trib1 is a lipid- and myocardial infarction–associated gene that regulates hepatic lipogenesis and VLDL production in miceJournal of Clinical Investigation, 2010
- Fatty Liver Is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: the Framingham Heart StudyHepatology, 2010
- MAST3: a novel IBD risk factor that modulates TLR4 signalingGenes & Immunity, 2008
- Liver fat is reproducibly measured using computed tomography in the Framingham Heart StudyJournal of Gastroenterology and Hepatology, 2008
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansNature Genetics, 2008
- The Role of the Microsomal Triglygeride Transfer Protein in AbetalipoproteinemiaAnnual Review of Nutrition, 2000